116 related articles for article (PubMed ID: 37997957)
1. Rapamycin-based inhaled therapy for potential treatment of COPD-related inflammation: production and characterization of aerosolizable nano into micro (NiM) particles.
Craparo EF; Cabibbo M; Scialabba C; Casula L; Lai F; Cavallaro G
Biomater Sci; 2024 Jan; 12(2):387-401. PubMed ID: 37997957
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel rapamycin loaded nano- into micro-formulation for treatment of lung inflammation.
Craparo EF; Drago SE; Quaglia F; Ungaro F; Cavallaro G
Drug Deliv Transl Res; 2022 Aug; 12(8):1859-1872. PubMed ID: 35182368
[TBL] [Abstract][Full Text] [Related]
3. Inhalable Formulation Based on Lipid-Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast.
Craparo EF; Cabibbo M; Scialabba C; Giammona G; Cavallaro G
Biomacromolecules; 2022 Aug; 23(8):3439-3451. PubMed ID: 35899612
[TBL] [Abstract][Full Text] [Related]
4. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
6. Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery.
Kaviarasi B; Rajana N; Pooja YS; Rajalakshmi AN; Singh SB; Mehra NK
Int J Pharm; 2023 Jun; 640():123006. PubMed ID: 37137420
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin-Loaded Polymeric Nanoparticles as an Advanced Formulation for Macrophage Targeting in Atherosclerosis.
Craparo EF; Cabibbo M; Conigliaro A; Barreca MM; Musumeci T; Giammona G; Cavallaro G
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33916918
[TBL] [Abstract][Full Text] [Related]
8. Inhalable polymeric microparticles as pharmaceutical porous powder for drug administration.
Craparo EF; Cabibbo M; Emanuele Drago S; Casula L; Lai F; Cavallaro G
Int J Pharm; 2022 Nov; 628():122325. PubMed ID: 36309290
[TBL] [Abstract][Full Text] [Related]
9. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
[TBL] [Abstract][Full Text] [Related]
10. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
11. Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.
Ozeki T; Beppu S; Mizoe T; Takashima Y; Yuasa H; Okada H
Pharm Res; 2006 Jan; 23(1):177-83. PubMed ID: 16267631
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier.
d'Angelo I; Costabile G; Durantie E; Brocca P; Rondelli V; Russo A; Russo G; Miro A; Quaglia F; Petri-Fink A; Rothen-Rutishauser B; Ungaro F
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):170-181. PubMed ID: 29035132
[TBL] [Abstract][Full Text] [Related]
13. Magnetic core-shell nanoparticles for drug delivery by nebulization.
Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
[TBL] [Abstract][Full Text] [Related]
14. Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells.
Patra A; Satpathy S; Hussain MD
Int J Nanomedicine; 2019; 14():8095-8104. PubMed ID: 31632020
[TBL] [Abstract][Full Text] [Related]
15. Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.
Patel M; Desai A; Kansara V; Vyas B
AAPS PharmSciTech; 2023 Jun; 24(6):142. PubMed ID: 37353671
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.
McBride AA; Price DN; Lamoureux LR; Elmaoued AA; Vargas JM; Adolphi NL; Muttil P
Mol Pharm; 2013 Oct; 10(10):3574-81. PubMed ID: 23964796
[TBL] [Abstract][Full Text] [Related]
17. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
Wang Y; Kho K; Cheow WS; Hadinoto K
Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
[TBL] [Abstract][Full Text] [Related]
18. Sustained-Release Powders Based on Polymer Particles for Pulmonary Delivery of Beclomethasone Dipropionate in the Treatment of Lung Inflammation.
Craparo EF; Drago SE; Costabile G; Ferraro M; Pace E; Scaffaro R; Ungaro F; Cavallaro G
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111733
[TBL] [Abstract][Full Text] [Related]
19. Micro vs. nano: PLGA particles loaded with trimethoprim for instillative treatment of urinary tract infections.
Brauner B; Schwarz P; Wirth M; Gabor F
Int J Pharm; 2020 Apr; 579():119158. PubMed ID: 32081799
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
